Resistance to Vitamin D or Parathyroid Hormone
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001242|
Recruitment Status : Recruiting
First Posted : November 4, 1999
Last Update Posted : January 10, 2018
Patients with confirmed or suspected conditions with a resistance to vitamin D or parathyroid hormone (PTH) will be admitted for diagnosis and treatment, and inclusion in other studies pertaining to similar conditions.
This study will provide information about problems relating to calcium in the blood, urine, and bones. Patients in this study will undergo a general evaluation / check-up to give researchers an idea of each person's condition or disease. Patients will receive treatment based on their diagnosis and asked to provide specimen samples for further research studies.
|Condition or disease|
|Hypocalcemia Pseudohypoparathyroidism Albright Hereditary Osteodystrophy Rickets|
|Study Type :||Observational|
|Estimated Enrollment :||99999999 participants|
|Official Title:||Studies of States With Resistance to Vitamin D and Parathyroid Hormone|
|Study Start Date :||September 29, 1989|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001242
|Contact: Lee S Weinstein, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Lee S Weinstein, M.D.||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|